The right fiber for the right disease: An update on the psyllium seed husk and the metabolic syndrome

Journal of Clinical Gastroenterology

Volumn 44, Issue SUPPL. 1, 2010, Pages

  Giacosa, Attilio ^a   Rondanelli, Mariangela ^b  

^a Policlinico di Monza ^*  (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

dietary fibre; metabolic syndrome; psyllium

Indexed keywords

ALPHA TOCOTRIENOL; BETA GLUCAN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISPAGULA; LIPID; TRIACYLGLYCEROL;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BARLEY; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONFERENCE PAPER; DIETARY FIBER; DYSLIPIDEMIA; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; HEART DISEASE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OAT; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; SATIETY; SEED HUSK; SOLUBILITY; TRIACYLGLYCEROL BLOOD LEVEL; VISCOSITY; WEIGHT REDUCTION;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DIETARY FIBER; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HUMANS; METABOLIC SYNDROME X; PSYLLIUM; SATIETY RESPONSE; SEEDS; TREATMENT OUTCOME; TRIGLYCERIDES; WEIGHT LOSS;

EID: 77956056703     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181e123e7     Document Type: Conference Paper

References (24)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med. 1998;15:539-553.
2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol. 2005;4:198-203.
3. Zimmet P, Magliano D, Matsuzava Y, et al. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12:295-300.
4. Meigs JB. Metabolic syndrome: in search of a clinical role. Diabetes Care. 2004;27:2761-2763.
5. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289-2304.
6. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006;83:1237-1247.
7. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007;92:399-404.
8. Position of the American Dietetic Association: Health Implications of Dietary Fiber. J Am Dietetic Assoc. 2008;108:1716-1731.
9. Brown L, Rosner B,WilletWW, et al. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30-42.
10. Food and Drug Administration. Food labeling: health claims; final rule. Rockville, MD: US Department of Health and Human Services, 1997. Internet: http://vm.cfsan.fda.gov/-lrd/ fr970123.html.
11. Anderson JW, Zettwoch N, Feldman T, et al. Cholesterollowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med. 1988;148:292-296.
12. Gupta RR, Agrawal CG, Singh GP, et al. Lipid-lowering efficacy of psyllium hydrophilic mucilloid in non insulin dependent diabetes mellitus with hyperlipidaemia. Indian J Med Res. 1994;100:237-241.
13. Sprecher DL, Harris BV, Goldberg AC, et al. Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets. Ann Intern Med. 1993;119:545-554.
14. Solá R, Godá s G, Ribalta J, et al. Effects of soluble fiber (Plantago ovata husk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease. Am J Clin Nutr. 2007;85:1157-1163.
15. Meigs JB. Epidemiology of the metabolic syndrome, 2002. Am J Manag Care. 2002;8:S283-S292.
16. Anderson JW, Davidson MH, Blonde L, et al. Long term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr. 2000;71:1433-1438.
17. Matheson HB, Colò n IS, Story JA. Cholesterol 7 alphahydroxylase activity is increased by dietary modification with psyllium hydrocolloid, pectin, cholesterol and cholestyramine in rats. J Nutr. 1995;125:454-458.
18. Hannan EL. Evaluating and improving the quality of care for acute myocardial infarction: can regionalization help? JAMA. 2006;295:2177-2179.
19. Ziai SA, Larijani B, Akhoondzadeh S, et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 2005;102:202-207.
20. Sierra M, Garcia JJ, Fernandez N, et al. Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr. 2002;56: 830-842.
21. Song YJ, Sawamura M, Ikeda K, et al. Soluble dietary fibre improves insulin sensitivity by increasing muscle GLUT-4 content in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2000;27:41-45.
22. Galisteo M, Sánchez M, Vera R, et al. A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. JNutr. 2005;135:2399-2404.
23. Cicero AF, Derosa G, Manca M, et al. Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens. 2007;29:383-394.
24. Burke V, Hodgson JM, Beilin LJ, et al. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension. 2001;38:821-826.